| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -1,8 k € | -108.7% | 20,5 k € | +135.3% | 8,7 k € | +185.9% | -10,2 k € | -216.9% | 8,7 k € | +45.9% | 6,0 k € | -58.6% | 14,4 k € | -62.0% | 37,9 k € | +231.8% | 11,4 k € | +119.5% | 5,2 k € | +4295.2% | -124,0 € | +97.7% | -5,3 k € | -655.0% | -707,2 € | +95.1% | -14,5 k € | -1029.6% | 1,6 k € | -85.8% | 10,9 k € | -44.4% | 19,7 k € | +25.4% | 15,7 k € | -16.1% | 18,7 k € | |
| EBITDA | -2,9 k € | -114.8% | 19,7 k € | +146.2% | 8,0 k € | +172.7% | -11,0 k € | -239.8% | 7,9 k € | +57.0% | 5,0 k € | -62.8% | 13,5 k € | -63.8% | 37,2 k € | +242.8% | 10,8 k € | +146.1% | 4,4 k € | +579.4% | -919,0 € | +85.3% | -6,2 k € | -365.9% | -1,3 k € | +90.9% | -14,7 k € | -1220.5% | 1,3 k € | -87.4% | 10,4 k € | -45.4% | 19,1 k € | +32.1% | 14,5 k € | -17.1% | 17,4 k € | |
| Operating profit | -2,9 k € | -114.8% | 19,7 k € | +1984.0% | 943,6 € | +104.5% | -21,1 k € | -838.4% | -2,2 k € | +55.9% | -5,1 k € | -262.9% | 3,1 k € | -90.7% | 33,8 k € | +484.5% | 5,8 k € | +759.2% | -876,0 € | +86.2% | -6,3 k € | +45.7% | -11,7 k € | -80.1% | -6,5 k € | +57.6% | -15,3 k € | -1828.5% | 883,2 € | -91.3% | 10,1 k € | -33.8% | 15,3 k € | +72.1% | 8,9 k € | +174.1% | 3,2 k € | |
| Profit/loss | -2,6 k € | -113.2% | 19,9 k € | +5375.9% | 363,8 € | +101.7% | -21,8 k € | -764.3% | -2,5 k € | +48.3% | -4,9 k € | -335.5% | 2,1 k € | -93.6% | 32,6 k € | +478.3% | 5,6 k € | +499.6% | -1,4 k € | +80.3% | -7,2 k € | +42.3% | -12,4 k € | -53.1% | -8,1 k € | +46.2% | -15,0 k € | -675.9% | 2,6 k € | -82.9% | 15,2 k € | +5.0% | 14,5 k € | +93.3% | 7,5 k € | +415.6% | 1,5 k € | |
| Equity | 23,6 k € | -10.0% | 26,3 k € | +313.5% | 6,4 k € | +6.1% | 6,0 k € | -78.5% | 27,8 k € | -8.3% | 30,3 k € | -13.9% | 35,2 k € | +6.3% | 33,1 k € | +6105.4% | 534,0 € | +110.5% | -5,1 k € | -38.2% | -3,7 k € | -206.8% | 3,5 k € | -78.2% | 15,9 k € | -33.8% | 24,0 k € | -38.6% | 39,0 k € | +7.2% | 36,4 k € | +72.0% | 21,2 k € | +217.9% | 6,7 k € | +885.8% | -847,0 € | |
| Total assets | 31,4 k € | +7.3% | 29,3 k € | -14.2% | 34,1 k € | +5.7% | 32,3 k € | -27.2% | 44,3 k € | -10.2% | 49,3 k € | -19.8% | 61,5 k € | +79.4% | 34,3 k € | +201.8% | 11,4 k € | -30.2% | 16,3 k € | -25.1% | 21,7 k € | -23.8% | 28,5 k € | -22.0% | 36,6 k € | +20.2% | 30,4 k € | -34.9% | 46,7 k € | -1.1% | 47,2 k € | +10.9% | 42,6 k € | -12.5% | 48,7 k € | +3.4% | 47,1 k € | |
| Cash | 14,0 k € | +194.2% | 4,8 k € | -83.6% | 29,0 k € | +83.3% | 15,8 k € | +17.3% | 13,5 k € | +127.3% | 5,9 k € | -9.1% | 6,5 k € | +253.1% | 1,8 k € | -70.3% | 6,2 k € | +7.5% | 5,8 k € | -5.8% | 6,2 k € | -28.7% | 8,6 k € | +9.0% | 7,9 k € | -39.4% | 13,1 k € | -1.9% | 13,3 k € | -20.5% | 16,8 k € | +33.0% | 12,6 k € | -11.9% | 14,3 k € | +75.1% | 8,2 k € | |
| Debts | 659,3 € | -77.9% | 3,0 k € | -89.2% | 27,7 k € | +5.7% | 26,3 k € | +59.1% | 16,5 k € | -13.1% | 19,0 k € | -27.7% | 26,3 k € | +2205.4% | 1,1 k € | -89.5% | 10,8 k € | -49.4% | 21,4 k € | -15.9% | 25,4 k € | +1.4% | 25,1 k € | +21.4% | 20,6 k € | +220.0% | 6,5 k € | -16.2% | 7,7 k € | -29.0% | 10,8 k € | -49.1% | 21,3 k € | -49.3% | 42,0 k € | -12.3% | 47,9 k € | |
Source: Belgian Official Gazette
Private company with limited liability · Villers-la-Ville · incorporated on 21/11/1988
Private company with limited liability loss-making in the latest fiscal year. Cash position rising (+194.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CENTRE DE MALADIES THROMBOTIQUES is a Private company with limited liability incorporated in 1988. Its registered office is in Villers-la-Ville.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.